The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
 
Subotheni Thavaneswaran
Research Funding - AstraZeneca (Inst); Elevation Oncology (Inst); Roche/Genentech (Inst)
 
Frank Po-Yen Lin
No Relationships to Disclose
 
Christine E Napier
No Relationships to Disclose
 
John P. Grady
No Relationships to Disclose
 
Mandy L. Ballinger
Honoraria - Roche (I)
Research Funding - Amgen (I); AstraZeneca (I); Bayer (I); Elevation Oncology (I); George Clincal (I); Lilly (I); Microba (I); Pfizer (I); Roche (I); Seagen (I); Sun Pharma (I)
Travel, Accommodations, Expenses - Amgen (I)
 
Maya Kansara
No Relationships to Disclose
 
Peter S. Grimison
Research Funding - Daiichi Sankyo Europe GmbH (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai (Inst); Epizyme (Inst); Genentech (Inst); Janssen-Cilag (Inst); Medimmune; MSD (Inst); Pfizer (Inst); Pfizer (Inst); PTC Therapeutics (Inst); PTC Therapeutics (Inst); QED Therapeutics (Inst); Tilray (Inst)
 
Nick Pavlakis
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck KGaA; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - Bayer (Inst); Pfizer (Inst); Roche (Inst)
 
Mark Ka Wong
Consulting or Advisory Role - MSD Oncology
Speakers' Bureau - MSD Oncology; Sirtex Medical
 
Katrin Marie Sjoquist
Honoraria - BMS; Merck; MSD; Novotech (Inst); Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
David Goldstein
Honoraria - AstraZeneca; Boehringer Ingelheim; Sun Biopharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Seagen; sun biopharma
Research Funding - Amgen (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); pfizer (Inst); Zucero Therapeutics (Inst)
 
Lorraine A. Chantrill
Honoraria - Amgen; Amgen; Merck; SERVIER
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
David Morgan Thomas
Employment - Australian Unity
Honoraria - Roche
Research Funding - Amgen; AstraZeneca; Bayer; Elevation Oncology; George Clincal (Inst); InterVenn Biosciences; Lilly (Inst); Microba (Inst); Pfizer; Roche; Seagen (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Amgen